This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Coca-Cola Nestlé Refreshments Company (E)
Ariño, AfricaCase SM-1635-EStrategyThe Coca-Cola Nestlé Refreshments Company (CCNR) began operations in 1991 as a joint venture (JV) between Coca-Cola and Nestlé. Both companies had manufactured and marketed a ready-to-drink coffee-based drink in Japan very successfully. Aware of a large potential world market and of the difficulties associated with launching a new product category on a worldwide basis, the two companies decided to combine their respective capabilities for this pu...Starting at €5.74
-
Coca-Cola Nestlé Refreshments Company (E)
Ariño, AfricaCase SM-1635StrategyCoca-Cola Nestlé Refreshments Company (CCNR) entró en funcionamiento en 1991 como una joint venture constituida por Coca-Cola (CC) y Nestlé (N). Ambas compañías habían producido y comercializado con gran éxito una bebida de café para el mercado japonés. Conscientes del enorme potencial del producto en el mercado mundial y de las dificultades asociadas al lanzamiento de una nueva categoría de producto a nivel global, ambas empresas decidieron comb...Starting at €5.74
-
Comergent Technologies Inc.: Enterprise E-Commerce, Teaching Note
Rangan, V. Kasturi; Bellfor, MarieTeaching Note HBS-507087-EMarketingTeaching Note to (505-016). An abstract is not available for this product.Starting at €0.00
-
The Pharmacy - Teaching Note
Recoder E.; Ariño, AfricaTeaching Note ASNT-6-EStrategyStarting at €0.00
-
-
La farmacia - Nota del Instructor
Recoder E.; Ariño, AfricaTeaching Note ASNT-6StrategyMaterial complementario del caso ASN-19.Starting at €0.00
-
La farmacia
Recoder E.; Ariño, AfricaCase ASN-73StrategyLa familia Galeno atraviesa una situación económica difícil. En este contexto, la Sra. Galeno debe decidir acerca del traslado de su farmacia a un nuevo emplazamiento. Esta publicación está basada en el caso homónimo de los mismos autores.Starting at €8.20
-
Gilead: Hepatitis-C Access Strategy (A)
Rangan, V. Kasturi; Rangan, Vikram; Bloom, David E.Case HBS-515025-EGilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the disease. The company had earned accolades for its work in HIV/AIDS, where its innovative medicines now accounted for 60% of all patients on Anti-Retroviral (ARV) medicines. Much of thi...Starting at €8.20
-
Sanofi Pasteur: The Dengue Vaccine Dilemma
Rangan, V. Kasturi; Bloom, David E.; Dessain, Vincent; Billaud, EmilieCase HBS-514074-EIn 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a good balanced immune answer, it had a proof of efficacy of only 30%, far below the 70% mark the company had targeted. Guillaume Leroy, vice president of the Dengue Company at Sanofi Pa...Starting at €8.20
-
FreeMove in Early 2008: Creating Value through Strategic Alliances in the Mobile Telecommunications Industry - Teaching Note
Riehl F.; Ariño, AfricaTeaching Note DGT-36-EStrategyNote prepared as an aid to instructors in the classroom use of case DG-1469-E.Starting at €0.00